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Intraductal papillary mucinous neoplasia (IPMN) is one of the cystic neoplasias of the
pancreas. The imaging findings provide that these tumors are differentiated from the other
cystic lesions of the pancreas, especially from the chronic pancreatitis, where the treat-
ment protocol is completely different. Therefore, the correct diagnosis and classification of
the IPMN ensures that the patient receives the correct approach and the appropriate sur-
gery, if necessary. The purpose of this study is to emphasize the imaging findings of the
different types of the IPMN and the changes in the management protocol of the patients
according to these radiological findings.
Copyright © 2016, The Authors. Published by Elsevier Inc. under copyright license from the
University of Washington. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Intraductal papillary mucinous neoplasia (IPMN) of the
pancreas are the subgroup of neoplasms formed by
mucinous cells that are located in the main pancreatic duct
or in its branches. It is a premalignant disease also called
mucinous ductal ectasia or ductectatic cystadenoma [1,2].
Different from the other common cystic lesions of the
pancreas, there is no gender discrimination in IPMN, and it
is most frequently observed in the sixth decade of life. Acute
pancreatitis is defined as one of the main symptoms ofcompeting interests.
(Z. Ozmen).
blished by Elsevier Inc. u
ND license (http://creativIPMN. It has been reported in different studies that the
incidence of acute pancreatitis in patients with IPMN varies
between 12% and 67% [3]. Patients have recurrent pancrea-
titis attacks and abdominal pain that are because of duct
obstruction formed due to intense mucin production or
tumor. The dilated ducts those are full of mucin show high
T2 and variable T1-signal intensity in magnetic resonance
(MR) depending on the fluid content of the mucin. The aim
of this study is to present 2 patients who had IPMN diag-
nosis of different types and who had surgeries due to
different imaging findings.nder copyright license from the University of Washington. This is
ecommons.org/licenses/by-nc-nd/4.0/).
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A 49-year-old male patient was admitted to our department
with recurrent abdominal pain and was evaluated. The
patient had been to another hospital 3 years prior with an
abdominal pain complaint. In the blood analyses of the
patient, the amylase and lipase values were observed as being
elevated, and as a result, the patient was diagnosed with
pancreatitis. In the ultrasonography (US), computerized
tomography (CT), and MR examinations in that hospital, a
cystic lesion was observed and was diagnosed as a pancreatic
pseudocyst developed secondary to the pancreatitis attacks in
the pancreas body. The patient was given treatment for
pancreatitis and was followed up for a pancreatic pseudocyst
diagnosis. The patient had MR and endoluminal US imaging
performed in various hospitals and was controlled. However,
meanwhile, the abdominal pain and pancreatitis attacks
continued. The patient then was admitted to the general
surgery department of our hospital with abdominal pain
complaint. In the biochemical analysis of the patient, the
amylase and lipase values were determined to be 1,800 U/L
and 923 U/L, respectively. The other biochemical parameters
were normal. No abnormalities were determined in the
physical examination other than the pain that stretched along
the epigastrium like a belt. When the physical examination
and laboratory analyses were evaluated together, the patient
was diagnosed with acute pancreatitis. The patient then
was guided to our department for abdominal US evaluation.
US examination was applied using Toshiba Aplio 500 2012 US
device and 3.5 MHZ pvt-375BT convex probe. In the US
examination, it was determined that there was segmental
cystic dilation causing lobulated contour of the size ofFig. 1 e The segmental cystic dilation of the main pancreatic du
bordering the lobule, associated with the dilated pancreatic duc
the periphery (long arrow). No flowwas observed within the lesi
mm in width (arrow head) in the US (D). The sub-branch dilatio55 45mmat the pancreatic duct on the body of the pancreas,
associated with the dilated pancreatic duct, with thick septa
in the periphery and solid nodular components that projected
into the lumen, the largest of which was 13  12 mm in size;
and in which no color fills or spectral flow forms were
observed in colored Doppler US (Fig. 1). The pancreatic duct
showed dilation that was up to 4.8 mm (Fig. 1D). Upon these
findings, dynamic contrast abdomen MR and MR chol-
angiopancreatography (MRCP) were planned for further
examinations. Dynamic contrast-enhanced MR examination
of the upper abdomen was performed with the 1.5 Tesla
General Electric MR device by using an abdominal coil. In
dynamic MR, there was segmental cystic dilation causing
lobulated contour of the size 55  45 mm at the pancreatic
duct on the body of the pancreas. Segmental cystic dilation
had solid nodular components in its periphery, projecting into
the lumen, the largest of which was 13  12 mm in size; and
containing septa, showing hypointense signal properties in
T1-weighted (W) series and showing clear hyperintense signal
properties in T2W series, whose nodular solid components
were contrasted after paramagnetic contrast matter applica-
tion (Figs. 2, 3). It was observed that the main pancreatic duct
was dilated in the MRCP bulk proximally and distally; and it
was also observed that, especially in the distal section, the
dilation in the pancreatic duct continued in the form of mil-
limetric expansions in the sub-branches. There were filling
defects representing solid components in the cystic bulk
lesion periphery (Fig. 4). The visual properties in the dynamic
MR and MRCP were evaluated as being consistent with intra-
ductal papillary mucinous neoplasia (IPMN).
The Whipple operation was performed on the patient.
After the operation, the specimen was evaluated in terms of
histopathology. In macroscopic examination, dilation inct in the abdominal US (A, B) on the body of the pancreas,
t (asterisks); solid components projecting into the lumen in
on in colored Doppler US (C). Themain pancreatic duct is 4.8
n seen in the MR cannot be distinguished.
Fig. 2 e The segmental cystic dilation of themain pancreatic duct on the body of the pancreas (asterisk), bordering the lobule
in axial T2W (A) and axial contrasted T1W (B) series, with smooth borders, associated with the dilated pancreatic duct.
There are sub-branch dilations (short arrow) associated with the main pancreatic duct (A-C). There are contrasted solid
nodular components (long arrow) and septa in the T1W (D) series after the contrast administration, in the periphery
projecting into the lumen.
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segmental cystic dilation of the size of 8  4.5  3 cm in the
main ductus structure and villiformmucosal projections were
detected (Fig. 5).
In terms of histopathology, tumoral formation that created
papillary proliferations in the pancreatic duct lumen showingFig. 3 eNonenhancing areas of axial fat saturated without contra
is seen in the pancreatic duct in the body of the pancreas (A); a
component (short white arrows), which shows the homogeneo
contrast T1W (C).segmental cystic dilation was observed. The papillary struc-
tures were located on the pseudostratified columnar epithe-
lium, contained dysplasia at a medium level, and were mainly
in the form of intestinal epithelial morphology. No areas were
observed in the sections that wouldmake us consider invasion
(Fig. 6). With these findings, the case was diagnosed as IPMN.st T1W in the periphery of segmental cystic dilation, which
xial fat saturated with contrast T1W (B); and the solid
us contrast in the series of coronal fat saturated with
Fig. 4 e There is dilation in the proximal and distal main
pancreatic duct and the sub-branches of the segmental
cystic dilation in MRCP.
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The 71-year-old female patient was admitted to the general
surgery polyclinic with an abdominal pain complaint. In the
physical examination, the abdominal pain did not reveal any
characteristics. Because the alanine aminotransferase: 52,
aspartate aminotransferase: 63, and alkaline phosphatase:
275 levels were found to be higher than the normal values in
biochemical analysis, she was guided to our department for
abdominal US examination. However, due to intense gas, the
pancreas could not be evaluated. MRI was applied, as the
patient did not consent to have CT performed due to the ra-
diation. Therefore, a dynamic contrast abdomen MR and
MRCP were planned for the patient. This process was per-
formed with the 1.5 Tesla General Electric MR device by using
an abdominal coil. In the dynamic abdomen MR and MRCP, it
was observed that there weremultiple cysts that began in the
uncinated process and proceeded through the whole of the
pancreas till the pancreatic tail. They did not cause any clearFig. 5 e Segmental cystic dilation in the main pancreatic
ductus lumen, erosion in the mucosa, ulcer bleeding, and
mucosal projections.lobulation in the pancreas contour and reached a greater size
in the beginning of the pancreas and in the uncinated pro-
cess; the largest was 26 mm in size. Their boundaries could
not be distinguished from each other. They showed hypo-
intense signal characteristics in T1W series and hyperin-
tense signal characteristics in T2W series, which were
contracted in T1W series after paramagnetic contrast sub-
stance application, and they did not have solid components.
These cysts were clearly associated with themain pancreatic
duct. No clear dilation was detected in the pancreatic duct.
There were no contrast enhanced solid components within
the cysts (Fig. 7). The proximal choledoch showed dilation
reaching up to 11 mm at its widest. The gallbladder was
distended, and the intrahepatic bile ducts were in the central
area andwere dilated in both lobes secondary to the pressure
of the cysts (Fig. 8). The lesion was evaluated as being a sub-
branch IPMN of the pancreas. After the patient was evaluated
again, it was observed that she had obstructive jaundice, and
she was operated on in another medical center for cysts on
the upper section of the pancreas. Upon histopathologic ex-
amination of the sample taken from her, the diagnosis was
IPMN.Discussion
IPMN of the pancreas is one of the cystic tumors of the
pancreas that is observed very rarely. It has 3 sub-branches:
main duct IPMN; IPMN of the sub-branches; and mixed-type,
in which both forms are found together [4]. The main duct
type IPMN is characterized by the widespread or segmented
dilation of the pancreatic duct. Since this situation is similar
to the clinical and radiological findings of chronic pancreatitis,
it is not always possible to recognize main pancreatic duct
IPMN. Since the duct is greatly expanded, it may be mistaken
as cysts.
In recent years, a common view about the normal values of
the pancreatic duct has been established in the guidelines.
According to this view, the upper limit of the normal
pancreatic duct is accepted as 5 mm. That common view has
increased the sensitivity for the radiological diagnosis of main
duct type IPMN without decreasing its specificity. It is sug-
gested in the guidelines that, if the width of the main
pancreatic ductus is between 5 and 9 mm, it should be
considered as a suspicious (risky) feature. If the diameter of
the main pancreatic ductus is above 10 mm, it should be
accepted as a high-risk factor for the main duct type IPMN.
Pancreatic pseudocysts should be taken into consideration in
the differential diagnosis because patients with IPMN have
pancreatitis attacks in their history [5].
In our first case, who had pancreatic attacks in his history,
the dilation in the pancreatic duct had taken the shape of a
cyst, and as a result, the patient was diagnosed with pancre-
atic pseudocyst and had been followed for 3 years by various
hospitals. During the follow-ups, the patient received US, CT,
MRCP, and endoluminal US examinations. It has been proven
that MRCP and MR are more effective than endoscopic retro-
grade cholangiopancreatography and CT in imaging of the
ductal system in patients with IPMN [6,7]. The dilated main
pancreatic duct may be visualized especially with T2W MR
Fig. 6 e The papillary tumoral formation (H.E. £ 40), which stretches to the ductus lumen (A), showing villous structure in
some places. Papillary structures (H.E. £ 100) with pseudostratified columnar cells (B). In some places, the intracytoplasmic
mucin content is clear. H. E., hematoxylin eosin.
Fig. 7 e The gallbladder is hydropic in axial T2W (A, B) series, and the choledoch seems dilated (thick white arrow). The
intrahepatic bile ducts have become clear in the central area. Neighboring hyperintense cysts in the pancreas are visible.
These cysts are in bigger size in the uncinated process. The cysts are observed in hypointense form (asterisks) in axial T1W (C)
series. In contrasted T1W (D) series, there is not an enhanced solid component (asterisks). In axial T1W (E) and contrasted
T1W (F) series, many hypointense cysts that are associated with the pancreatic duct are visible and are smaller (thin white
arrow) than those located in the uncinated process in the pancreas body and tail part and do not have solid component.
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Fig. 8 e In MRCP (A, B), cysts characterized with hyperintense signal features in various sizes along the pancreas are visible.
The pancreatic duct is of normal width (white arrow). The choledoch is dilated, and the gallbladder is observed in distention.
The cyst has exerted pressure on the choledoch (white arrow).
Table 1 e Follow-up and treatment indications of IPMN.
Indications of surgery Indications of EUS Indications of follow-up
(1) Obstructive jaundice þ cyst in the
upper part of the pancreas.
(2) The solid bulk that holds contrast
within the cyst.
(3) The width of the main pancreatic duct
being more than 10 mm.
(4) EUS (þ).
(1) If indications of surgery ().
(a) Pancreatitis (þ).
(b) Cyst is bigger than 3 cm.
(c) Main pancreatic duct is 5-9
mm.
(d) Solid nodule that does not hold
contrast.
(e) Atrophy in pancreas distal.
(1) Indications of surgery ().
(2) EUS ().
EUS, endoluminal US.
EUS (þ) findings (a) definite mural nodule, (b) main pancreatic duct involvement, and (c) sitology doubtful or malignity.
R a d i o l o g y Ca s e R e p o r t s 1 1 ( 2 0 1 6 ) 4e1 0 9sequences or MRCP. The filling defects with low signal in-
tensity in the MRCP sequences represent the papillary struc-
tures and mural nodules. Papillary structures and mural
nodules are closely related to malignancy development [6].
Main duct tumors may cause mild dilation in the pancreatic
duct until the ampulla level.
Talamini et al. conducted a study of 473 patients with
chronic pancreatitis and 45 patients with IPMN, and deter-
mined that 12% of the patients with IPMN had chronic
pancreatitis. It was reported that the 2% of the patients with
chronic pancreatitis were mistakenly diagnosed as IPMN.
IPMNmistakenly being diagnosed as chronic pancreatitis may
cause serious delays in treatment [8e10]. In our first case,
despite the examinations and tests conducted, there was a
delay of nearly 3 years.Table 2 e Follow-up protocol of IPMN.
Cyst size
Below 1 cm 1-2 cm 2-3 cm Bigger than
3 cm
CT/MR CT/MR EUS every
3-6 months
Close
follow-up
Every 2-3 years Once
a year
Later MR/EUS EUS and MR
every 3-6
months
CT, computerized tomography; EUS, endoluminal US.Sub-branch type IPMN is more common in the uncinated
process; however, it may also be observed in the body or in the
tail; it is observed as small bunches of cysts with lobule sides
and compartments [11e13]. No clear dilation in the pancreatic
duct is observed.
In our second case, there were cysts that continued along
the whole pancreas but were larger in size in the uncinated
process of the pancreas. No dilation was detected in the
pancreatic duct. Although there were no solid components,
the patient had symptoms of obstructive jaundice, and the
patient underwent surgery.
IPMN has a relatively better prognosis when compared
with other pancreatic cystic neoplasms. Themain ductus type
and mixed-type IPMN have high malignancy potential and
require surgical treatment [14]. IPMN treatment is determined
by considering the size and location of the tumor, main
pancreatic duct involvement, the nearby soft tissue compo-
nent, the age of the patient, surgical risk factors, and similar
variables [15e17]. The treatment and follow-up options for
IPMN are given in detail in Tables 1 and 2 [17].Teaching point
There are 3 types of intraductal papillary mucinous neo-
plasms of the pancreas: sub-branch type, main duct type and
a mixed-type consisting of both sub-branch and main duct.
Radiological imaging and treatment options may change
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 4e1 010depending on the type and size of the tumor, width of the
main pancreatic duct, and components of the accompanying
soft tissue. Moreover, it can be misdiagnosed as diseases such
as chronic pancreatitis and pancreatic pseudocyst.r e f e r e n c e s
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